AM Yeager

1.3k total citations
21 papers, 1.0k citations indexed

About

AM Yeager is a scholar working on Hematology, Immunology and Epidemiology. According to data from OpenAlex, AM Yeager has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in AM Yeager's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). AM Yeager is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (4 papers) and Immunotherapy and Immune Responses (4 papers). AM Yeager collaborates with scholars based in United States. AM Yeager's co-authors include GW Santos, RJ Jones, John R. Wingard, ML Graham, HG Braine, Maohua Zhou, SD Smith, JE Wagner, Charlotte Shinn and AD Hess and has published in prestigious journals such as Blood, American Journal of Psychiatry and American Journal of Roentgenology.

In The Last Decade

AM Yeager

21 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
AM Yeager United States	17	565	276	202	196	150	21	1.0k
Jordi Sierra Spain	14	590 1.0×	375 1.4×	272 1.3×	193 1.0×	54 0.4×	26	1.0k
Josette Champagne Canada	15	326 0.6×	148 0.5×	288 1.4×	151 0.8×	60 0.4×	26	896
Patrick Elder United States	17	380 0.7×	237 0.9×	166 0.8×	126 0.6×	58 0.4×	71	768
M.J. de Vries Netherlands	18	215 0.4×	211 0.8×	241 1.2×	155 0.8×	86 0.6×	35	893
Süreyya Savaşan United States	16	286 0.5×	99 0.4×	261 1.3×	208 1.1×	70 0.5×	81	943
Yigal Barak Israel	13	244 0.4×	98 0.4×	132 0.7×	127 0.6×	117 0.8×	26	673
Mark Goodman United States	16	287 0.5×	261 0.9×	137 0.7×	260 1.3×	94 0.6×	52	903
Aleksandar Mijović United Kingdom	21	1.0k 1.8×	211 0.8×	207 1.0×	326 1.7×	86 0.6×	53	1.6k
Torstein B. Rø Norway	20	266 0.5×	268 1.0×	184 0.9×	547 2.8×	82 0.5×	44	1.2k
K. Hugh‐Jones United Kingdom	16	254 0.4×	72 0.3×	102 0.5×	122 0.6×	109 0.7×	35	649

Countries citing papers authored by AM Yeager

Since Specialization

Citations

This map shows the geographic impact of AM Yeager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AM Yeager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AM Yeager more than expected).

Fields of papers citing papers by AM Yeager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AM Yeager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AM Yeager. The network helps show where AM Yeager may publish in the future.

Co-authorship network of co-authors of AM Yeager

This figure shows the co-authorship network connecting the top 25 collaborators of AM Yeager. A scholar is included among the top collaborators of AM Yeager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AM Yeager. AM Yeager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Waller, Edmund K., et al.. (2000). Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells. Leukemia. 14(3). 412–418. 24 indexed citations

2.

Yeager, AM, et al.. (1998). Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin. Leukemia. 12(2). 182–191. 4 indexed citations

3.

Zhou, Mi, et al.. (1998). Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Leukemia. 12(11). 1756–1763. 29 indexed citations

4.

Yeager, AM, et al.. (1996). Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice. Blood. 87(8). 3237–3244. 15 indexed citations

5.

Zhou, Maohua, et al.. (1995). Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood. 85(6). 1608–1614. 96 indexed citations

6.

Wingard, John R., et al.. (1992). Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood. 79(4). 1068–1073. 73 indexed citations

7.

Yeager, AM, Vogelsang Gb, RJ Jones, et al.. (1992). Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]. Blood. 79(11). 3031–3035. 68 indexed citations

8.

Wingard, John R., et al.. (1992). Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood. 79(4). 1068–1073. 5 indexed citations

9.

Yeager, AM, et al.. (1992). Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. Blood. 80(9). 2425–2428. 65 indexed citations

10.

Yeager, AM, GB Vogelsang, RJ Jones, et al.. (1992). Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]. Blood. 79(11). 3031–3035. 55 indexed citations

11.

Yeager, AM, et al.. (1992). Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation. Blood. 80(9). 2425–2428. 68 indexed citations

12.

Yeager, AM, et al.. (1991). Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood. 78(12). 3312–3316. 32 indexed citations

13.

Rosen, Jules, et al.. (1991). Sleep disturbances in survivors of the Nazi Holocaust. American Journal of Psychiatry. 148(1). 62–66. 80 indexed citations

14.

Yeager, AM, et al.. (1991). Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood. 78(12). 3312–3316. 29 indexed citations

15.

Yeager, AM, et al.. (1990). Development and characterization of a cyclophosphamide-resistant subline of acute myeloid leukemia in the Lewis x Brown Norway hybrid rat. Blood. 76(6). 1209–1213. 21 indexed citations

16.

Rowley, SD, RJ Jones, Steven Piantadosi, et al.. (1989). Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood. 74(1). 501–506. 73 indexed citations

17.

Rowley, SD, R. G. Wyn Jones, S Piantadosi, et al.. (1989). Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood. 74(1). 501–506. 62 indexed citations

18.

Wingard, John R., Chen Dy, WH Burns, et al.. (1988). Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood. 71(5). 1432–1437. 148 indexed citations

19.

Jones, B, SS Kramer, Rein Saral, et al.. (1988). Gastrointestinal inflammation after bone marrow transplantation: graft-versus-host disease or opportunistic infection?. American Journal of Roentgenology. 150(2). 277–281. 27 indexed citations

20.

Jones, B, E K Fishman, SS Kramer, et al.. (1986). Computed tomography of gastrointestinal inflammation after bone marrow transplantation. American Journal of Roentgenology. 146(4). 691–695. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact